2009
DOI: 10.5144/0256-4947.2009.413
|View full text |Cite
|
Sign up to set email alerts
|

Is CCR5-Δ32 Mutation Associated with Diabetic Nephropathy in Type 2 Diabetes?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
8
0

Year Published

2011
2011
2015
2015

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 7 publications
1
8
0
Order By: Relevance
“…Our previous findings demonstrated that the CCR5 Δ 32 mutation was not prevalent in either southeast Iranian T2D patients without nephropathy or T2D patients with nephropathy [36]. The control group in our study also carried a very low prevalence of this mutation (0.66 %) [36]. In agreement with our previous results, Kalev and colleagues reported that there was no association between the CCR5 Δ 32 mutation and native Estonian T2D patients [40].…”
Section: The Status Of the Ccr5 δ 32 Mutation In Type 2 Diabetessupporting
confidence: 93%
See 2 more Smart Citations
“…Our previous findings demonstrated that the CCR5 Δ 32 mutation was not prevalent in either southeast Iranian T2D patients without nephropathy or T2D patients with nephropathy [36]. The control group in our study also carried a very low prevalence of this mutation (0.66 %) [36]. In agreement with our previous results, Kalev and colleagues reported that there was no association between the CCR5 Δ 32 mutation and native Estonian T2D patients [40].…”
Section: The Status Of the Ccr5 δ 32 Mutation In Type 2 Diabetessupporting
confidence: 93%
“…Some studies proposed that CCR5 can be involved in the recruitment of immune cells to the pancreas; hence, it seems that the genetic and epigenetic factors that alter CCR5 expression, including the CCR5 Δ 32 mutation, can be considered as an important risk factor in the pathogenesis of T2D and its complications including nephropathy. Our previous findings demonstrated that the CCR5 Δ 32 mutation was not prevalent in either southeast Iranian T2D patients without nephropathy or T2D patients with nephropathy [36]. The control group in our study also carried a very low prevalence of this mutation (0.66 %) [36].…”
Section: The Status Of the Ccr5 δ 32 Mutation In Type 2 Diabetesmentioning
confidence: 63%
See 1 more Smart Citation
“…In SLE, the inflammatory process is initiated by lymphocytic infiltration into tissue spaces, and the biological distribution of lymphocytes appears to be determined by the expression of chemokines receptors, including CCR5 [35,36]. The deletion of 32 pb of CCR5 leads to a decreased expression and dysfunction of CCR5 protein and could exert a role in the immune system-related diseases [37].…”
Section: Discussionmentioning
confidence: 99%
“…The crucial role of cytokine networks in orientating immune responses is well documented [26]. Several factors such as infectious agents, hormonal conditions, and cytokine gene polymorphisms regulate expression and secretion of cytokines [27].…”
Section: Discussionmentioning
confidence: 99%